Ovation Alternative Income Master Fund, LP – Trademark Portfolio

Entity Type: 13

Ovation Alternative Income Master Fund, LP holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 4 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include HMR and ELITE MEDICAL RECEIVABLES SOLUTIONS, LLC. The owner is based in Austin, TX.

Suite 1440

Austin, TX 78703

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Ovation Alternative Income Master Fund, LP's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (4 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Ovation Alternative Income Master Fund, LP have?

Ovation Alternative Income Master Fund, LP has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Ovation Alternative Income Master Fund, LP file in?

Ovation Alternative Income Master Fund, LP files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Ovation Alternative Income Master Fund, LP's most well-known trademarks?

Ovation Alternative Income Master Fund, LP's registered trademark portfolio includes well-known marks such as HMR and ELITE MEDICAL RECEIVABLES SOLUTIONS, LLC. These are among 4 currently registered trademarks in the portfolio.

What is Ovation Alternative Income Master Fund, LP's trademark registration success rate?

Ovation Alternative Income Master Fund, LP has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.